Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

26. Psychopharmacological Treatments 613(1998). A randomized trial of nortriptylene for smoking cessation. Arch InternMed, 158, 2035–2039.Rabinowitz, J., Cohen, H., & Atias, S. (2002). Outcomes of naltrexone maintenancefollowing ultra rapid opiate detoxification versus intensive inpatient detoxification.Am J Addict, 11, 52–56.Rainey, P. M., Friedland, G., McCance-Katz, E. F., Andrews, L., Mitchell, S. M.,Charles, C., & Jatlow, P. (2000). Interaction of methadone with didanosine (ddI)and stavudine (d4T). J Acquir Immune Defic Syndr, 24, 241–248.Rainey, P. M., Friedland, G. H., Snidow, J. W., McCance-Katz, E. F., Mitchell, S. M.,Andrews, L., et al. (2002).The pharmacokinetics of methadone following coadministrationwith a lamivudine/zidovudine combination tablet in opiate dependentsubjects (NZTA4003). Am J Addict, 11, 66–74.Raistrick, D., Hay, A., & Woldd, K. (1996). Methadone maintenance and tuberculosistreatment. Br Med J, 313(7062), 925–926.Rickels, K., Case, W. G., Schweizer, E., Garcia-Espana, F., & Fridman, R. (1991). Longtermbenzodiazepine users 3 years after participation in a discontinuation program.Am J Psychiatry, 148, 757–761.Rickels, K., De Martinis, N., Rynn, M., & Mandos, L. (1999). Pharmacologic strategiesfor discontinuing benzodiazepine treatment. J Clin Psychopharmacol, 19, 12S–16S.Rickels, K., Schweizer, E., Case, W. G., & Garcia-Espana, F. (1988). Benzodiazepinedependence, withdrawal severity, and clinical outcome: Effects of personality. PsychopharmacolBull, 24, 415–420.Rounsaville, B. J., & Kosten, T. R. (2000). Treatment for opioid dependence: Qualityand access. JAMA, 283, 1337–1339.Roy-Byrne, P. P., Ward, N. G., & Donnelly, P. J. (1989). Valproate in anxiety andwithdrawal syndromes. J Clin Psychiatry, 50(Suppl), 44–48.Rubio, G., Jimenez-Arriero, M. A., Ponce, G., & Palomo, T. (2001). Naltrexone vs.acamprosate: One year follow-up of alcohol dependence treatment. Alcohol Alcohol,36, 419–425.Saxon, A. J., Whittaker, S., & Hawker, C. S. (1989). Valproic acid, unlike otheranticonvulsants, has no effect on methadone metabolism: Two cases. J Clin Psychiatry,50, 228–229.Scherbaum, N., Klein, S., Kaube, H., Kienbaum, P., Peters, J., & Gastpar, M. (1998).Alternative strategies of opiate detoxification: Evaluation of the so-called ultrarapiddetoxification. Pharmacopsychiatry, 31, 205–209.Schmitz, J. M., Stotts, A. L., Rhoades, H. M., & Grabowski, J. (2001). Naltrexone andrelapse prevention treatment for cocaine-dependent patients. Addict Behav, 26,167–180.Schottenfeld, R. S., Pakes, J., O’Connor, P., Chawarski, M., Oliveto, A., & Kosten, T.R. (2000). Thrice weekly versus daily buprenorphine maintenance. Biol Psychiatry,47, 1072–1079.Sees, K. L., Delucci, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., et al.(2000). Methadone maintenance vs. 180-day psychosocially enriched detoxificationfor treatment of opioid dependence. JAMA, 283, 1303–1310.Sellers, E., Higgins, G., Tompkins, D., & Romach, M. (1992). Serotonin and alcoholdrinking. NIDA Res Monogr, 119, 141–145.Senay, E. C., Dorus, W., Goldberg, F., & Thornton, W. (1977). Withdrawal from meth-